Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.90
Bid: 3.60
Ask: 3.84
Change: -0.09 (-2.36%)
Spread: 0.24 (6.667%)
Open: 3.60
High: 3.90
Low: 3.60
Prev. Close: 3.81
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Report & Accounts and AGM Notice Published

7 May 2021 15:50

RNS Number : 9781X
Plant Health Care PLC
07 May 2021
 

 

7 May 2021

Plant Health Care plc

("Plant Health Care" or the "Company")

 

Publication of Annual Report and Accounts and Notice of AGM

 

Plant Health Care plc (AIM:PHC), a leading provider of novel patent-protected biological products to global agricultural markets announces that it has today published its Annual Report and Accounts for the year ended 31 December 2020. A copy is available from the Company's website at:

https://www.planthealthcare.com/investors/reports-and-presentations 

The Company's Annual General Meeting (AGM) is to be held on Monday, 14 June 2021 at 1:00pm at the offices of Arden Partners plc, 125 Old Broad Street, London EC2N 1AR. 

As a result of current UK Government COVID-19 restrictions, which includes banning gatherings of more than six people, the Company's AGM will not be held in its usual format. The Company has arranged the AGM with the maximum number of shareholders and directors allowed to ensure that the AGM is quorate and as a result shareholders are advised not to attend. Should shareholders do so it is likely that they will be not be permitted entry.

 

Notice of the AGM has also been published and a copy of is available from the Company's website at:

 

https://www.planthealthcare.com/investors/shareholder-information/meetings-and-voting

 

The Company is planning a virtual investor presentation via the Investor Meet Company platform, to enable shareholders to engage with the Company prior to submitting their proxy. Details of the presentation will be announced nearer the time. Should shareholders wish to pre-register for this event please click on the link below and register on the Investor Meet Company platform; you will receive notification when the meeting is created.

 

https://www.investormeetcompany.com/plant-health-care-plc/register-investor 

 

 

Plant Health Care plc

Tel: +1 919 926 1600

Chris Richards, CEO

Arden Partners plc - Nomad & Joint Broker

Tel: +44 (0) 20 7614 5900

John Llewellyn-Lloyd / Benjamin Cryer

Cenkos Securities plc - Joint Broker

Tel: +44 (0) 20 7391 8900

Neil McDonald / Peter Lynch

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMBSGDUCSGDGBR
Date   Source Headline
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.